| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |